Key Points: GI symptoms are the most common adverse effects, ranging from expected nausea and vomiting to gastroparesis and, rarely, functional obstruction Delayed gastric emptying has important airway implications and a cautious approach to airway management is warranted Biliary disease is one of the most clinically significant complications, particularly early in treatment and with rapid weight loss Pancreatitis is rare, and current evidence does not support a strong causal relationship EDKA and AKI are uncommon but important to recognize in the right context Conclusions: GLP-1 receptor agonists have transformed the management of diabetes and obesity, with clear benefits in weight loss, glycemic control, and cardiovascular outcomes
Common questions in this guide What is the standard treatment for systemic primary carnitine deficiency
Endocannabinoid overactivity and intestinal inflammation
Vukojevic et al., 2018)
As a result, the cagrilintide peptide aims to reduce appetite, boost fullness, and regulate blood sugar
Frequently Asked Questions About Henry Meds Pricing Why is Henry's advertised price lower than what I would pay monthly